Adial Appoints Renowned Pharmaceutical Executive Cary J. Claiborne to Board of Directors - GlobeNewswire -BoardProspects

Adial Appoints Renowned Pharmaceutical Executive Cary J. Claiborne to Board of Directors

GlobeNewswire Nov 3 2021 BoardMoves

(GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the appointment of Cary J. Claiborne to the Board of Directors, increasing the number of board members to seven...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- KKR representatives resign from Kodak's board also categorized in BoardMoves
- Boeing CFO Joins JPMorgan Board also categorized in BoardMoves
- Microsoft Adds New Board Member also categorized in BoardMoves
- Time Inc. Appoints Griffin CEO also categorized in BoardMoves
- A New Diversity Monitor for the S.E.C. - NYTimes.com also categorized in BoardMoves
- Molson Coors Adds Two to Board also categorized in BoardMoves
- Diverse Slate of Corporate Directors Become NACD Fellows - GlobeNewswire also published in GlobeNewswire
- Thompson Joins Microsoft Board also categorized in BoardMoves
- NACD BoardVision - NACD BoardVision – “The role of the board as company spokesperson” - Resources - NACD also mentions National Association of Corporate Directors
- Rand Logistics Announces Organizational and Corporate Governance Changes also published in GlobeNewswire

Search:
Categories
1. BoardProspects Features:
  Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned
Authors
- Adial Pharmaceuticals, Inc